Liu, Chun-Yu <br/><br/>
The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells.  [electronic resource] 

 -  Experimental & molecular medicine  08 2017 
 - e366 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2092-6413 
<br/><br/><label>Standard No.: </label>10.1038/emm.2017.114  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Disease-Free Survival<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Indoles--pharmacology<br/>Kaplan-Meier Estimate<br/>Mice<br/>Mice, Inbred BALB C<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Tyrosine Phosphatase, Non-Receptor Type 6--genetics<br/>Protein-Tyrosine Kinases--metabolism<br/>RNA, Small Interfering--genetics<br/>STAT3 Transcription Factor--genetics<br/>Triple Negative Breast Neoplasms--drug therapy<br/>Xenograft Model Antitumor Assays